A study suggests that GLP-1 agonist drugs, like Ozempic, may reduce overdose risks and aid in addiction treatment. Further ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.

Green tea, low-carb diets, and time-restricted eating are trending for 2024 wellness resolutions. Here’s what experts say works—and what doesn’t.

New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish ...

Weight-loss medications surged in popularity this year. A survey from Kaiser Family Foundation found one in eight adults have ...

In a festive spirit, Elon Musk, the 53-year-old CEO of Tesla and SpaceX, shared a humorous image of himself dressed as Santa ...

Nearly 75% of Americans are classified as overweight or obese. Addressing our nation's health crisis requires much more than ...

Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...

Jameela Jamil, who has been vocal about undereating and eating disorders, denounced "Ozempic heroin chic" as a body trend. She encouraged others, while fortifying her own beliefs, to resist societal ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 500.39% and ...

Plenty of people want to lose weight in 2025, but here's why many may actually get there thanks to GLP-1 drugs.